All sounds good. Opinions?
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019 – Year-over-year revenue grows 13%, gross margin improves 120 basis points, non-GAAP operating profit up 18%– Quarterly dividend increases 5% to $0.39 per share– ResMed well-positioned for first quarter fiscal year 2020 and beyondNote: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.comSAN DIEGO, July 25, 2019 – ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended June 30, 2019.
Fourth Quarter 2019 Highlights
● Revenue increased 13% to $705.0 million; up 15% on a constant currency basis
● Gross margin expanded 120 bps to 59.3%
● Net operating profit decreased 18%; non-GAAP operating profit up 18%
● GAAP diluted earnings per share of $0.48; non-GAAP diluted earnings per share of $0.95
● Quarterly dividend increased by 5% to $0.39 per share Full Year 2019 Highlights
● Revenue increased 11% to $2.6 billion; up 13% on a constant currency basis
● Gross margin expanded 80 bps to 59.0%
● Net operating profit increased 7%; non-GAAP operating profit up 18%
● GAAP diluted earnings per share of $2.80; non-GAAP diluted earnings per share of $3.64
“We finished fiscal year 2019 with double-digit revenue growth to $2.6 billion and operating profit up 18% on a non-GAAP basis. Recent mask launches have driven market share gains while continued adoption of our SaaS solutions is driving both revenue growth and a steady margin profile,” said Mick Farrell, ResMed’s CEO. “We delivered another quarter of operating leverage, which gives us flexibility as we execute on our long-term strategy to provide innovative products, software, and solutions to improve health outcomes, createefficiencies, and reduce overall healthcare system costs. Our pipeline is solid; we are well-positioned as we enter fiscal year 2020 on a trajectory to improve 250 million lives in out-of-hospital healthcare in 2025.”
- Forums
- ASX - By Stock
- Ann: ResMed Announces Results for the Fourth Quarter of FY2019
All sounds good. Opinions?ResMed Inc. Announces Results for the...
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$35.17 |
Change
-0.270(0.76%) |
Mkt cap ! $22.28B |
Open | High | Low | Value | Volume |
$35.01 | $35.31 | $35.01 | $27.67M | 787.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | $35.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$35.23 | 3393 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 2450 | 35.000 |
2 | 340 | 34.950 |
2 | 228 | 34.900 |
2 | 260 | 34.880 |
2 | 158 | 34.800 |
Price($) | Vol. | No. |
---|---|---|
35.290 | 750 | 1 |
35.450 | 16341 | 3 |
35.500 | 476 | 2 |
35.800 | 200 | 1 |
35.900 | 520 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |